tiprankstipranks
Advertisement
Advertisement

KSPHF Stock Latest News

Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio
Company AnnouncementsKissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio
18d ago
Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
PremiumCompany Announcements
Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
1M ago
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
PremiumCompany Announcements
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
2M ago
Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
PremiumCompany Announcements
Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
2M ago
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
PremiumCompany Announcements
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
2M ago
Kissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet
PremiumPre-EarningsKissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet
2M ago
Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids
Premium
Company Announcements
Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids
4M ago
Kissei Pharmaceutical initiated with a Neutral at UBS
Premium
The Fly
Kissei Pharmaceutical initiated with a Neutral at UBS
4M ago
Kissei Pharmaceutical Adjusts Dividend Payment Date
PremiumCompany Announcements
Kissei Pharmaceutical Adjusts Dividend Payment Date
4M ago
Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment
PremiumCompany Announcements
Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment
5M ago
Kissei Pharmaceutical Revises Financial Forecast with Positive Outlook
PremiumCompany Announcements
Kissei Pharmaceutical Revises Financial Forecast with Positive Outlook
5M ago
Kissei Pharmaceutical Reports Financial Results with Increased Net Sales
PremiumCompany Announcements
Kissei Pharmaceutical Reports Financial Results with Increased Net Sales
5M ago
Kissei Pharmaceutical Co (KSPHF) Q2 Earnings Cheat Sheet
PremiumPre-EarningsKissei Pharmaceutical Co (KSPHF) Q2 Earnings Cheat Sheet
5M ago
Kissei Pharmaceutical’s Promising Phase III Study on Spinocerebellar Degeneration
Premium
Company Announcements
Kissei Pharmaceutical’s Promising Phase III Study on Spinocerebellar Degeneration
5M ago
KSPHF
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment
Premium
Company Announcements
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment
5M ago
KSPHF
Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments
PremiumCompany Announcements
Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments
5M ago
KSPHF
Kissei Pharmaceutical’s Fostamatinib Study: A Potential Game-Changer for Chronic Thrombocytopenic Purpura
PremiumCompany Announcements
Kissei Pharmaceutical’s Fostamatinib Study: A Potential Game-Changer for Chronic Thrombocytopenic Purpura
5M ago
KSPHF
Kissei Pharmaceutical’s Promising Phase II Trial for Parkinson’s Treatment
PremiumCompany Announcements
Kissei Pharmaceutical’s Promising Phase II Trial for Parkinson’s Treatment
5M ago
KSPHF
Kissei’s Linzagolix Gains Marketing Approval in Taiwan
PremiumCompany Announcements
Kissei’s Linzagolix Gains Marketing Approval in Taiwan
6M ago
Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal
PremiumCompany AnnouncementsKissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal
6M ago
Kissei Pharmaceutical Completes Sale of Investment Securities
Premium
Company Announcements
Kissei Pharmaceutical Completes Sale of Investment Securities
6M ago
Kissei Pharmaceutical Secures Licensing for TED Treatments in Japan
Premium
Company Announcements
Kissei Pharmaceutical Secures Licensing for TED Treatments in Japan
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >